Improved synthesis of 2′-deoxy-2′-[18F]-fluoro-1-β-d-arabinofuranosyl-5-iodouracil ([18F]-FIAU)

Nuclear Medicine and Biology

Volumn 37, Issue 4, 2010, Pages 439-442

  Anderson, Harry ^a   Pillarsetty, NagaVaraKishore ^b   Cantorias, Melchor ^b   Lewis, Jason S ^b  

^a Advion BioSciences Inc   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

FIAU; HSV1 tk; Microfluidics; PET

Indexed keywords

2' DEOXY 2' FLUORO 1 BETA DEXTO ARABINOFURANOSYL 5 IODOURACIL F 18; FLUORINE 18; TRACER; UNCLASSIFIED DRUG;

ARTICLE; AUTOMATION; CATALYSIS; DEPROTECTION REACTION; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROFLUIDICS; REACTION TIME; RELIABILITY; SILYLATION; STRUCTURE ANALYSIS;

ARABINOFURANOSYLURACIL; CATALYSIS; FLUORINE RADIOISOTOPES; KINETICS; MESYLATES; TRIMETHYLSILYL COMPOUNDS;

EID: 77952551337     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2010.01.003     Document Type: Article

References (16)

1. Serganova I., Mayer-Kukuck P., Huang R., Blasberg R. Molecular imaging: reporter gene imaging. Handb Exp Pharmacol 2008, 167-223.
2. Ponomarev V. Nuclear imaging of cancer cell therapies. J Nucl Med 2009, 50:1013-1016.
3. Keller P.M., Fyfe J.A., Beauchamp L., Lubbers C.M., Furman P.A., Schaeffer H.J., et al. Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. Biochem Pharmacol 1981, 30:3071.
4. De Clercq E. Antivirals and antiviral strategies. Nat Rev Microbiol 2004, 2:704.
5. Gambhir S.S., Herschman H.R., Cherry S.R., Barrio J.R., Satyamurthy N., Toyokuni T., et al. Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2000, 2:118-138.
6. Doubrovin M., Ponomarev V., Beresten T., Balatoni J., Bornmann W., Finn R., et al. Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci U S A 2001, 98:9300.
7. Koehne G., Doubrovin M., Doubrovina E., Zanzonico P., Gallardo H.F., Ivanova A., et al. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol 2003, 21:405-413.
8. Dobrenkov K., Olszewska M., Likar Y., Shenker L., Gunset G., Cai S., et al. Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging. J Nucl Med 2008, 49:1162-1170.
9. Pomper M.G., Hammond H., Yu X., Ye Z., Foss C.A., Lin D.D., et al. Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models. Cell Res 2009, 19:370-379.
10. 18F]FFEAU, and other imaging probes. J Nucl Med 2008, 49:637-648.
11. 18F]FEAU: a novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression. Mol Imaging Biol 2008, 10:82-91.
12. 18F]FEAU) as markers for suicide gene expression. Eur J Nucl Med Mol Imaging 2007, 34:822-829.
13. Alauddin M.M., Conti P.S., Fissekis J.D. A general synthesis of 2'-deoxy-2'-[F-18]fluoro-1-beta-d-arabinofuranosyluracil and its 5-substituted nucleosides. J Labell Compounds Radiopharm 2003, 46:285.
14. 18F]labelled FAU, FMAU, FBAU, FIAU. Nucl Med Biol 2003, 30:215.
15. Vorbruggen H., Bennua B. Nucleoside synthesis: 19. New simplified nucleoside synthesis. Tetrahedron Lett 1978, 1339-1342.
16. Yamaguchi T., Saneyoshi M. Synthetic nucleosides and nucleotides: 21. On the synthesis and biological evaluations of 2'-deoxy-alpha-d-ribofuranosyl nucleosides and nucleotides. Chem Pharm Bull 1984, 32:1441-1450.